Gummy Active Loading and Serving Architecture

Suppose the product brief requires:

100 mg of a relevant active/day.

That does not necessarily mean the manufacturer adds 100 mg of raw material.

If a raw material contains only a fraction of the desired constituent, more material is required.

Conceptually:

RAW MATERIAL REQUIRED = TARGET ACTIVE AMOUNT / ACTIVE FRACTION IN RAW MATERIAL

For example, purely as arithmetic:

Target active = 100 mg

Raw material standardized to 50% of that active

100 / 0.50 = 200 mg raw material

This is before considering product-specific assay tolerances, manufacturing overages where appropriate, or other specification requirements.

The formulation needs to work with the actual material mass, not only the front-label number.

Suppose the product requires:

1,000 mg raw material/day.

At:

2 gummies/day

1,000 / 2 = 500 mg/gummy

At:

4 gummies/day

1,000 / 4 = 250 mg/gummy

Increasing gummies/day reduces the amount required in each unit.

But it does not make the problem disappear.

It moves part of the problem from formulation architecture into serving and commercial architecture.

Suppose each finished gummy hypothetically weighs:

3,000 mg.

At 500 mg material/gummy:

500 / 3,000 = 16.7%

At 250 mg material/gummy:

250 / 3,000 = 8.3%

This is useful information.

But it still does NOT establish whether either formulation is feasible.

Why?

Because 500 mg of a neutral, compatible material is not equivalent to 500 mg of:

• hygroscopic material;
• insoluble mineral;
• strongly bitter botanical;
• oil;
• acidic material;
• heat-sensitive ingredient;
• ingredient that changes gel behaviour.

IMPORTANT:

Nominal active/material fraction is NOT a feasibility score.

Payload is multidimensional.

Think of a gummy as having a finite formulation-space budget.

The finished unit has to contain:

FUNCTIONAL MATERIAL

plus

THE MATRIX REQUIRED TO MAKE IT A SUCCESSFUL GUMMY.

That matrix may need:

• hydrocolloid;
• sweetening/bulking solids;
• water;
• acid/pH system;
• flavour;
• colour;
• processing aids;
• other required excipients.

As functional material occupies more of the unit, less formulation space remains for everything else.

The developer then has several possible levers:

• increase gummy weight;
• increase gummies per serving;
• change active source/form;
• change matrix architecture;
• change sensory architecture;
• change product format.

There is no guarantee that all of these are commercially desirable.

HYPOTHETICAL EXAMPLE ONLY.

Product requirement:

30 mg botanical extract/day

Serving:

1 gummy/day

Hypothetical finished gummy:

3 g = 3,000 mg

Nominal material fraction:

30 / 3,000 = 1%

From a mass perspective, the formulation has substantial remaining space.

But suppose the extract is:

• intensely bitter;
• strongly coloured;
• oxidation-sensitive;
• difficult to disperse uniformly.

The payload arithmetic looks easy.

The product development may not be.

PRINCIPLE:

Low material burden does not mean low formulation complexity.

HYPOTHETICAL EXAMPLE ONLY.

Target:

1,000 mg raw material/day.

ARCHITECTURE A

2 gummies/day

500 mg/gummy

Hypothetical 3 g finished gummy

500 / 3,000 = 16.7% nominal material fraction

Monthly unit count for 30 days:

60 gummies

ARCHITECTURE B

4 gummies/day

250 mg/gummy

Hypothetical 3 g finished gummy

250 / 3,000 = 8.3% nominal material fraction

Monthly unit count for 30 days:

120 gummies

Architecture B creates more matrix space per gummy.

But it doubles monthly unit count.

That may affect:

• bottle/pouch size;
• manufacturing quantity expressed as finished packs;
• packaging cost;
• shipping;
• consumer convenience;
• cost per daily serving.

There is no automatically better architecture.

The product system has to be optimized.

HYPOTHETICAL EXAMPLE ONLY.

Target:

5 g/day material requirement.

ARCHITECTURE A

2 gummies/day

2.5 g material/gummy

Hypothetical 4 g finished gummy

2.5 / 4 = 62.5% nominal material fraction

ARCHITECTURE B

5 gummies/day

1 g material/gummy

Hypothetical 4 g finished gummy

1 / 4 = 25% nominal material fraction

Monthly count:

150 gummies per 30 days

The arithmetic becomes less extreme in Architecture B.

But the consumer now requires 150 gummies per month.

That materially changes the commercial proposition.

CRITICAL:

Neither 62.5% nor 25% proves manufacturability.

These numbers describe mass balance only.

They do not prove:

• gel formation;
• depositability;
• acceptable texture;
• acceptable taste;
• unit uniformity;
• stability;
• commercial scale-up.

Imagine three gummy concepts each requiring:

300 mg of material.

MATERIAL A Neutral-tasting, stable, compatible powder.

MATERIAL B Strongly bitter botanical extract.

MATERIAL C Mineral source with unpleasant sensory character and a substantial insoluble fraction.

All three say:

300 mg.

But the development problems are different.

Milligrams describe quantity.

They do not describe behaviour.

A common shortcut is:

“Is the ingredient water soluble?”

That is useful information, but incomplete.

Depending on the formulation, development may also need to understand:

• dispersion;
• suspension;
• sedimentation;
• particle size;
• crystallization;
• oil/water behaviour;
• interaction with hydrocolloids;
• pH sensitivity;
• analytical recovery;
• heat exposure;
• moisture sensitivity.

A poorly soluble ingredient may still be formulatable.

A soluble ingredient may still create serious problems.

Solubility alone must not become CoManufacturing’s feasibility test.

Suppose a formulation can physically accept more functional material.

If increasing the dose creates:

• unacceptable bitterness;
• chalkiness;
• metallic character;
• excessive sourness;
• poor chew;
• grittiness;
• persistent aftertaste;

then the useful product capacity may already have been exceeded.

This gives us an important distinction:

PHYSICAL CAPACITY

versus

USEFUL PRODUCT CAPACITY.

CORE CO-MANUFACTURING PRINCIPLE:

Useful gummy capacity is the amount that can be delivered while preserving the required serving, sensory performance, manufacturability, stability and economics.

High functional loading can influence the manufacturing mass.

Relevant questions include:

• Is viscosity still suitable for depositing?
• Does material remain uniformly distributed?
• Does it settle during holding?
• Does the gummy set properly?
• Can it be demoulded?
• Does conditioning behave consistently?
• Are unit weights sufficiently controlled?
• Is active distribution sufficiently controlled?

This is where laboratory prototype and commercial manufacturing diverge.

A hand-prepared prototype can sometimes be processed immediately.

A production batch may spend materially more time in mixing, holding and depositing operations.

Commercial feasibility therefore has to be demonstrated using the intended manufacturing architecture. The gummy supplement manufacturing process sets out the scale-up and control questions that a payload decision creates.

More functional material may change:

• pH;
• water behaviour;
• water binding;
• physical structure;
• oxidation behaviour;
• active-active interactions;
• active-matrix interactions.

The direction is not universal.

Adding more active does not automatically increase or decrease stability.

It changes the system that needs to be validated.

This is another reason not to publish a universal payload threshold. The resulting specification belongs in a product-specific stability and water-activity plan.

HYPOTHETICAL ARITHMETIC ONLY.

Suppose a manufacturing quantity contains:

100,000 gummies.

At:

30 gummies/pack = approximately 3,333 theoretical packs

60 gummies/pack = approximately 1,667 theoretical packs

90 gummies/pack = approximately 1,111 theoretical packs

before production losses, retained samples, QC requirements or other deductions.

Now compare two serving architectures.

2 gummies/day:

60-count pack = 30-day supply.

4 gummies/day:

60-count pack = 15-day supply.

Same manufacturing quantity.

Different commercial architecture.

CoManufacturing should eventually translate:

gummy manufacturing quantity → finished packs → servings → days of supply → inventory requirement

rather than displaying MOQ as an isolated number.

A format change should be considered when delivering the target specification requires:

• too many gummies/day;
• an excessively large unit;
• unacceptable sensory compromises;
• poor manufacturing behaviour;
• questionable stability;
• excessive packaging;
• unattractive cost per serving.

That does not necessarily mean the ingredient “cannot be made into a gummy.”

It means another format may solve the whole product problem better.

Depending on the formulation, alternatives could include:

• powder;
• capsule;
• tablet;
• liquid;
• oral film for appropriately low-dose systems;
• another delivery architecture.

CoManufacturing should remain format-neutral.

Arithmetic comes first.

Testing comes next.

A meaningful feasibility program may need to establish:

INCORPORATION Can the required material be incorporated?

STRUCTURE Does the gummy form correctly?

SENSORY Are taste and texture acceptable?

UNIFORMITY Is the active distributed appropriately?

PROCESSABILITY Can the intended manufacturing process handle the formulation?

STABILITY Does the product remain within the required specification?

COMMERCIAL ARCHITECTURE Does the resulting serving and pack make sense?

Only after those questions are addressed should a founder treat the payload architecture as genuinely viable.

Evidence guide: Published evidence — supported by linked literature. · CoManufacturing experience — practical development reasoning, not a universal specification. · Manufacturer-specific — confirm against the selected process and supplier. · Project-specific / requires validation — prove with the actual formula, process, pack and market.

• Hu et al., “Perspective on Gummy Dietary Supplements Manufacturing and Testing,” Journal of Dietary Supplements (2026). PubMed · doi:10.1080/19390211.2026.2727022
• Adeleke and Abedin, “Characterization of Prototype Gummy Formulations Provides Insight into Setting Quality Standards,” AAPS PharmSciTech (2024). PubMed · doi:10.1208/s12249-024-02876-w
• Rivero et al., “Natural Ingredients-Based Gummy Bear Composition Designed According to Texture Analysis and Sensory Evaluation In Vivo,” Molecules (2019). PubMed

Published examples show that active-containing gummies require product-specific evaluation of quality, texture and sensory behaviour. They do not establish a universal active fraction or prove commercial manufacturability for another material or process.